Rocket Lab’s proposed acquisition of Iridium Communications has moved past one of the deal’s clearest regulatory gates. The Hart-Scott-Rodino antitrust waiting period has lapsed, removing a key barrier as the company advances toward the next stages of the transaction.

For $RKLB shareholders, the significance is less about a finish line than about momentum. Rocket Lab has also filed a Form S-4 registration statement, submitted applications to the Federal Communications Commission and said its capital strategy is underway—three pieces of deal machinery now turning in the same direction.

Rocket Lab, which describes itself as a global leader in launch services and space systems, announced the milestones in connection with its previously announced proposed acquisition of Iridium Communications. The company’s announcement presents the update as a coordinated step forward rather than a single regulatory headline.

Why the HSR milestone matters

The lapse of the Hart-Scott-Rodino waiting period removes a significant antitrust review hurdle. That does not mean every condition to closing has been satisfied, and it does not establish a closing date. It does, however, reduce one area of execution uncertainty for a transaction that must navigate multiple regulatory and financing tasks.

In deal terms, regulatory progress can change the texture of investor debate. Before a waiting period lapses, uncertainty can center on whether the transaction will clear a basic competition review. After it lapses, attention may shift toward the remaining approvals, the disclosures in the registration statement and the practical question of how the buyer intends to fund the combination.

Three signals, one execution story

The Form S-4 filing adds another important layer. A registration statement is a formal step in presenting transaction-related information to the market and moving the proposed combination through its required process. The filing does not, by itself, close the deal, but it indicates that Rocket Lab is advancing the transaction through a more developed phase of documentation and disclosure.

The FCC applications point to a separate regulatory workstream. Because the announcement identifies those applications as filed, investors can see that the transaction is not being handled solely as an antitrust or securities-law exercise. Communications-related review remains part of the path ahead, and the filings show that Rocket Lab has taken action on that front.

Then comes capital. Rocket Lab said its capital strategy is underway to fund the transaction. That wording matters because financing preparation is central to execution, yet the assignment provides no transaction terms, valuation figures, funding amounts or details of the proposed capital structure. Those missing details are not minor footnotes; they are among the items that may shape how shareholders evaluate dilution, leverage or other financing effects once more information becomes available.

What $RKLB shareholders may watch next

The latest milestones reduce uncertainty, but they do not erase it. Shareholders may focus on the contents and progress of the Form S-4, the status of the FCC applications and the details of Rocket Lab’s capital strategy as they emerge. Those developments could help clarify the remaining path to closing, while also showing how the proposed acquisition may affect the company’s financial and ownership structure.

Investors may also distinguish between process progress and transaction completion. The HSR waiting period has lapsed, the Form S-4 has been filed and FCC applications have been submitted. Each is concrete progress. None, based on the information provided, supplies a closing date or confirms that all required conditions have been met.

That distinction is especially important for a company operating in a capital-intensive sector. Rocket Lab’s stated position as a global leader in launch services and space systems gives the proposed combination a strategic frame, but strategy must still pass through regulatory review, disclosure, financing and closing mechanics. The market may reward a cleaner path to execution, yet it may also scrutinize the cost and structure of getting there.

The market’s next question

Rocket Lab’s update turns the acquisition story from a broad proposal into a sequence of visible milestones. Antitrust review has cleared its waiting-period hurdle. Securities filing activity is underway. FCC applications are in. Capital planning has begun.

The next phase will be about converting that progress into clarity. Until the company provides further details on transaction terms, funding and the remaining conditions, the central question for $RKLB shareholders is not simply whether the deal is advancing. It is whether the advancing process ultimately produces a structure that aligns the strategic ambition of the Iridium acquisition with the financial interests of Rocket Lab’s existing shareholders.